Filing Details

Accession Number:
0001209191-22-001994
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-05 19:24:13
Reporting Period:
2022-01-03
Accepted Time:
2022-01-05 19:24:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574700 Carol Moore C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94520
Svp Reg. & Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-03 19,059 $3.66 200,335 No 4 M Direct
Common Stock Disposition 2022-01-03 19,059 $7.00 181,276 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2022-01-03 19,059 $0.00 19,059 $3.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
150,941 2023-02-28 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a 10b5-1 plan.
  2. This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $7.000 to $7.005. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
  4. Not applicable.